US BANCORP \DE\ - GALERA THERAPEUTICS INC ownership

GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 41 filers reported holding GALERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of GALERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$525
-94.4%
3,0000.0%0.00%
Q2 2023$9,360
+21.9%
3,0000.0%0.00%
Q1 2023$7,680
+71.8%
3,0000.0%0.00%
Q4 2022$4,470
-25.5%
3,000
-11.3%
0.00%
Q3 2022$6,000
+50.0%
3,3830.0%0.00%
Q2 2022$4,000
+33.3%
3,383
+144.6%
0.00%
Q1 2022$3,000
-94.1%
1,383
-87.4%
0.00%
Q4 2021$51,000
-40.7%
10,962
+3.6%
0.00%
Q3 2021$86,000
-17.3%
10,5790.0%0.00%
Q2 2021$104,00010,5790.00%
Other shareholders
GALERA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 3,083,712$40,582,0002.92%
Novo Holdings A/S 3,409,021$44,863,0002.89%
NEA Management Company, LLC 4,362,986$57,417,0002.72%
SPHERA FUNDS MANAGEMENT LTD. 471,439$6,204,0000.51%
RA Capital Management 1,054,178$13,873,0000.42%
Rock Springs Capital Management LP 500,000$6,580,0000.21%
Tekla Capital Management LLC 416,666$5,483,0000.21%
Blackstone Inc. 1,678,984$22,095,0000.14%
Perceptive Advisors 325,000$4,277,0000.08%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,300,000$17,108,0000.04%
View complete list of GALERA THERAPEUTICS INC shareholders